IN185805B - - Google Patents

Info

Publication number
IN185805B
IN185805B IN2723DE1996A IN185805B IN 185805 B IN185805 B IN 185805B IN 2723DE1996 A IN2723DE1996 A IN 2723DE1996A IN 185805 B IN185805 B IN 185805B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Alfons Grunenberg
Patrick Bosche
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7779831&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN185805(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IN185805B publication Critical patent/IN185805B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN2723DE1996 1995-12-12 1996-12-06 IN185805B (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19546249A DE19546249A1 (de) 1995-12-12 1995-12-12 Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen

Publications (1)

Publication Number Publication Date
IN185805B true IN185805B (en:Method) 2001-05-05

Family

ID=7779831

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2723DE1996 IN185805B (en:Method) 1995-12-12 1996-12-06

Country Status (42)

Country Link
US (1) US5849752A (en:Method)
EP (1) EP0780390B1 (en:Method)
JP (1) JP4104687B2 (en:Method)
KR (1) KR100525146B1 (en:Method)
CN (1) CN1061348C (en:Method)
AR (1) AR005009A1 (en:Method)
AT (1) ATE221531T1 (en:Method)
AU (1) AU708006B2 (en:Method)
BG (1) BG62258B1 (en:Method)
BR (1) BR9605968A (en:Method)
CA (1) CA2192418C (en:Method)
CO (1) CO4480105A1 (en:Method)
CU (1) CU22774A3 (en:Method)
CZ (1) CZ288657B6 (en:Method)
DE (2) DE19546249A1 (en:Method)
DK (1) DK0780390T3 (en:Method)
EE (1) EE03474B1 (en:Method)
ES (1) ES2179910T3 (en:Method)
HR (1) HRP960558B1 (en:Method)
HU (1) HU226521B1 (en:Method)
ID (1) ID22625A (en:Method)
IL (1) IL119795A (en:Method)
IN (1) IN185805B (en:Method)
MA (1) MA24342A1 (en:Method)
MY (1) MY117492A (en:Method)
NL (1) NL300109I1 (en:Method)
NO (1) NO306725B1 (en:Method)
NZ (1) NZ299905A (en:Method)
PL (1) PL184885B1 (en:Method)
PT (1) PT780390E (en:Method)
RO (1) RO119782B1 (en:Method)
RU (1) RU2162468C2 (en:Method)
SA (1) SA96170492B1 (en:Method)
SG (1) SG47201A1 (en:Method)
SI (1) SI0780390T1 (en:Method)
SK (1) SK282805B6 (en:Method)
SV (1) SV1996000109A (en:Method)
TR (1) TR199600970A2 (en:Method)
TW (1) TW411340B (en:Method)
UA (1) UA35638C2 (en:Method)
YU (1) YU49485B (en:Method)
ZA (1) ZA9610405B (en:Method)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU731693B2 (en) * 1997-09-25 2001-04-05 Bayer Intellectual Property Gmbh Drug formulation having controlled release of active compound
DE19751948A1 (de) * 1997-11-24 1999-05-27 Bayer Ag Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
US6509327B1 (en) 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
ES2229786T3 (es) * 1998-11-10 2005-04-16 Bayer Healthcare Ag Preparacion farmaceutica de moxifloxacina.
DE19854357A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854356A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908449A1 (de) * 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
EP1562942A1 (en) * 2002-10-31 2005-08-17 Ranbaxy Laboratories, Ltd. Amorphous moxifloxacin hydrochloride
ES2332367T5 (es) * 2003-04-09 2013-12-17 Dr. Reddy's Laboratories Ltd. Forma cristalina III de clorhidrato de moxifloxacina anhidro y su procedimiento de preparación
US20060264635A1 (en) * 2003-08-05 2006-11-23 Chava Satyanarayana Process for the preparation of moxifloxacin hydrochloride
ITMI20032259A1 (it) 2003-11-20 2005-05-21 Chemi Spa Nuovo polimorfo dell'acido 1-ciclopropil-7-(s,s-2,8-diazabciclo-4.3.0-non-8-il)-6-fluoro-1,4-diidro-8-metossi-4-oxo-chinolin carbossilico cloridrato e metodi per la sua preparazione
EP1685130B1 (en) * 2003-11-20 2008-12-10 CHEMI S.p.A. Polymorphs of 1-cyclopropyl-7-([s,s] - 2,8-diazadicyclo [4.3.0] non-8-yl) -6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinoline carboxylic acid hydrochloride and methods for the preparation thereof
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
DE102004015981A1 (de) * 2004-04-01 2005-10-20 Bayer Healthcare Ag Neue kirstalline Form von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE102004063347A1 (de) * 2004-12-23 2006-07-13 Stada Arzneimittel Ag Gebrauchsfertige Gemcitabinlösungen und Gemcitabinlösungskonzentrate
WO2007033515A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation orale contenant de la moxifloxacine et son procédé de préparation
GB0612422D0 (en) * 2006-06-23 2006-08-02 Generics Uk Ltd Novel hydrate form
WO2008000418A2 (en) 2006-06-27 2008-01-03 Sandoz Ag New method for salt preparation
ES2303768B1 (es) * 2006-09-08 2009-06-05 Quimica Sintetica, S.A. Nueva forma cristalina de moxifloxacino clorhidrato.
KR101539561B1 (ko) * 2006-11-13 2015-07-27 씨아이피엘에이 엘티디. 목시플록사신 염산염의 합성방법
EP1992626A1 (en) * 2007-05-10 2008-11-19 Sandoz AG Process for the preparation of moxifloxacin hydrochloride
EP2083010A1 (en) * 2008-01-08 2009-07-29 Chemo Ibérica, S.A. Polymorphic Forms of Moxifloxacin hydrochloride and processes for preparation thereof
EP2154137A1 (en) 2008-08-04 2010-02-17 Chemo Ibérica, S.A. Crystalline form of moxifloxacin base
WO2010041100A1 (en) 2008-10-09 2010-04-15 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Using of organic solvents in wet granulation of moxifloxacin
EP2342204A1 (en) * 2008-11-06 2011-07-13 Hetero Research Foundation Novel polymorph of moxifloxacin hydrochloride
EP2837376A3 (de) 2008-12-08 2015-03-25 ratiopharm GmbH Kompaktiertes Moxifloxacin
KR20120025519A (ko) 2009-05-15 2012-03-15 레드엑스 파마 리미티드 산화환원 약물 유도체
WO2011121596A2 (en) * 2010-04-01 2011-10-06 Neuland Laboratories Ltd. Crystal modification of moxifloxacin hydrochloride
BRPI1106900A2 (pt) 2011-12-26 2013-11-05 Ems Sa Composição farmacêutica sólida compreendendo antibótico da familia das quinolonas e processo de sua obtenção
FR2992218B1 (fr) 2012-06-22 2015-01-23 Rivopharm Sa Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation
CN102924449B (zh) * 2012-10-30 2015-08-12 重庆福安药业集团庆余堂制药有限公司 盐酸莫西沙星h晶型及其制备方法和药物组合物
EP2928892B1 (en) 2012-12-04 2018-03-21 Mankind Pharma Ltd. An improved process for the preparation of moxifloxacin hydrochloride
RU2561037C2 (ru) * 2013-02-07 2015-08-20 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Антибактериальная фармацевтическая композиция и способ ее получения
EP2969004A4 (en) 2013-03-15 2016-09-21 Melinta Therapeutics Inc METHOD FOR THE TREATMENT OF INFECTIONS IN OVERWEIGHT AND ADIPOSIVE PATIENTS USING ANTIBIOTICS

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601567A1 (de) * 1986-01-21 1987-07-23 Bayer Ag 7-(azabicycloalkyl)-chinoloncarbonsaeure- und -naphthyridon-carbonsaeure-derivate
CN1019114B (zh) * 1986-03-31 1992-11-18 三共株式会社 喹啉-3-羟酸衍生物的制备方法
AU609974B2 (en) * 1988-05-18 1991-05-09 Warner-Lambert Company Improved process for the preparation of 5-amino-7- (substituted amino)-quinoline-3-carboxylic acids
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
RO108347B1 (ro) * 1989-10-30 1994-04-28 Bellon Labor Sa Roger DERIVATI DE BENZO-(b)-NAFTIRIDIN-1,8 SI PROCEDEU DE PREPARARE A ACESTORA
TW209865B (en:Method) 1992-01-10 1993-07-21 Bayer Ag
ATE207479T1 (de) * 1992-01-31 2001-11-15 Chugai Pharmaceutical Co Ltd Kristalle von derivaten von chinozon carbonsäure- hydraten
DE4234078A1 (de) * 1992-10-09 1994-04-14 Bayer Ag Chinoloncarbonsäuren
JP3268098B2 (ja) * 1992-12-25 2002-03-25 第一製薬株式会社 二環性環状アミン誘導体
ZA946853B (en) * 1993-09-10 1995-04-24 Daiichi Seiyaku Co Crystals of antimicrobial compound.
DE69504392T2 (de) * 1994-04-07 1999-02-11 Pfizer Inc., New York, N.Y. Verwendung von Trovafloxacin oder dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung von H.Pylori Infektionen

Also Published As

Publication number Publication date
ID22625A (id) 1999-12-02
ES2179910T3 (es) 2003-02-01
HUP9603428A2 (en) 1997-08-28
JP4104687B2 (ja) 2008-06-18
PL317415A1 (en) 1997-06-23
US5849752A (en) 1998-12-15
CN1061348C (zh) 2001-01-31
HRP960558A2 (en) 1998-02-28
CZ364696A3 (en) 1997-07-16
NO306725B1 (no) 1999-12-13
KR100525146B1 (ko) 2006-01-27
AU708006B2 (en) 1999-07-29
CU22774A3 (es) 2002-07-24
CO4480105A1 (es) 1997-07-09
AU7421696A (en) 1997-06-19
BG101043A (en) 1998-04-30
DE19546249A1 (de) 1997-06-19
EE9600201A (et) 1997-06-16
TR199600970A2 (tr) 1997-06-21
HU9603428D0 (en) 1997-01-28
MY117492A (en) 2004-07-31
TW411340B (en) 2000-11-11
NL300109I1 (nl) 2003-02-03
PL184885B1 (pl) 2003-01-31
BR9605968A (pt) 1998-08-18
IL119795A (en) 1998-12-27
MA24342A1 (fr) 1998-07-01
CZ288657B6 (cs) 2001-08-15
KR970042550A (ko) 1997-07-24
JPH09169757A (ja) 1997-06-30
YU65096A (sh) 1998-12-23
UA35638C2 (uk) 2001-04-16
CN1160052A (zh) 1997-09-24
CA2192418C (en) 2001-06-12
YU49485B (sh) 2006-08-17
EP0780390B1 (de) 2002-07-31
DK0780390T3 (da) 2002-11-11
SV1996000109A (es) 1997-10-23
SG47201A1 (en) 1998-03-20
NZ299905A (en) 1998-09-24
HRP960558B1 (en) 2002-04-30
RU2162468C2 (ru) 2001-01-27
PT780390E (pt) 2002-11-29
HUP9603428A3 (en) 1997-10-28
IL119795A0 (en) 1997-03-18
SA96170492B1 (ar) 2006-05-23
SI0780390T1 (en) 2002-10-31
AR005009A1 (es) 1999-04-07
CA2192418A1 (en) 1997-06-13
DE59609501D1 (de) 2002-09-05
SK159196A3 (en) 1997-10-08
NO965298D0 (no) 1996-12-11
NO965298L (no) 1997-06-13
MX9606325A (es) 1997-10-31
ATE221531T1 (de) 2002-08-15
BG62258B1 (bg) 1999-06-30
EE03474B1 (et) 2001-08-15
ZA9610405B (en) 1997-06-23
RO119782B1 (ro) 2005-03-30
EP0780390A1 (de) 1997-06-25
SK282805B6 (sk) 2002-12-03
HU226521B1 (en) 2009-03-30

Similar Documents

Publication Publication Date Title
DE69638352D1 (en:Method)
DE69637714D1 (en:Method)
BR122012014331A2 (en:Method)
BRPI9612258B1 (en:Method)
BRPI9612138B1 (en:Method)
IN185805B (en:Method)
CH0741373H1 (en:Method)
DK0727898T3 (en:Method)
BR7501503U (en:Method)
BR7502120U (en:Method)
DK126096A (en:Method)
CN3032692S (en:Method)
CN3038187S (en:Method)
CN3030542S (en:Method)
CN3030543S (en:Method)
CN3031001S (en:Method)
CN3031350S (en:Method)
CN3031655S (en:Method)
CN3031742S (en:Method)
CN3031926S (en:Method)
CN3032332S (en:Method)
CN3032390S (en:Method)
CN3032522S (en:Method)
CN3032568S (en:Method)
CN3030296S (en:Method)